Khademi B et al. [43] analyzed cytokine levels, specifically IFN-gamma (a Th1 marker) and IL-4 (a Th2 marker), in 55 benign tumors, 14 malignant tumors, and a control group. The gene discussed is IFNG; the disease is benign neoplasm.